The evolution of the initial manifestations and renal involvement of chinese patients with classical and late-onset Fabry disease at different sexes and ages
- PMID: 37020293
- PMCID: PMC10074707
- DOI: 10.1186/s12882-023-03138-w
The evolution of the initial manifestations and renal involvement of chinese patients with classical and late-onset Fabry disease at different sexes and ages
Abstract
Background: Fabry disease is a rare hereditary disease involving multiple organs, and there are few reports on how the initial manifestations and renal involvement of these patients with classical and late-onset phenotype evolve with sexes and ages. To improve clinicians' understanding of Fabry disease and avoid misdiagnoses by discussing the initial manifestations, first medical specialties visited and renal involvement development in patients.
Methods: This study collected relevant data from 311 Chinese Fabry disease patients (200 males, 111 females) and descriptive statistical analysis was used to analyze the evolution of the initial manifestations and renal involvement of patients with classical and late-onset phenotype at different sexes and ages.
Results: Regarding the age at manifestation onset, age at the first medical specialty visited and age at the diagnosis of Fabry disease, males were earlier than females, and males with classical phenotype were earlier than males with late-onset and females with classical phenotype. In both male and female patients, the initial manifestations of classical patients were mainly acroparesthesia, and the first medical specialty visited were mainly pediatrics and neurology. The initial manifestations of late-onset patients were mainly renal and cardiovascular involvement, and the first medical specialty visited were mainly nephrology and cardiology. In classical patients, both male and female, the initial manifestations of the preschool and the juvenile groups were mainly acroparesthesia, and the frequency of renal and cardiovascular involvement in the young group was higher than that in the preschool and juvenile groups. There was no obvious renal involvement in the preschool group, renal involvement was most common in the young group and the middle-aged and elderly group. Proteinuria can appear in classical male patients as early as approximately 20 years, and renal insufficiency can occur at approximately 25 years. With age, over 50% of classical male patients can develop varying degrees of proteinuria at the age of 25 and renal insufficiency at the age of 40. 15.94% of the patients progressed to dialysis or kidney transplantation, mainly classical males.
Conclusions: The initial manifestation of Fabry disease is affected by sex, age and classical/late-onset phenotype. The initial manifestations were mainly acroparesthesia and the frequency and degree of renal involvement increased gradually with aging in classical male patients.
Keywords: Classical phenotype; Evolution; Fabry disease; Initial manifestation; Renal involvement.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Correlation of enzyme activities and genotype with clinical manifestations in Chinese patients of different sexes with classical and late-onset Fabry disease.Front Med. 2025 Jun;19(3):523-537. doi: 10.1007/s11684-025-1131-9. Epub 2025 May 13. Front Med. 2025. PMID: 40358875
-
Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey: Underdiagnosis of late-onset phenotype.Medicine (Baltimore). 2017 Jul;96(29):e7387. doi: 10.1097/MD.0000000000007387. Medicine (Baltimore). 2017. PMID: 28723748 Free PMC article.
-
Musculoskeletal manifestations of Fabry disease: A retrospective study.Joint Bone Spine. 2016 Jul;83(4):421-6. doi: 10.1016/j.jbspin.2015.11.001. Epub 2015 Dec 14. Joint Bone Spine. 2016. PMID: 26697993
-
When and How to Diagnose Fabry Disease in Clinical Pratice.Am J Med Sci. 2020 Dec;360(6):641-649. doi: 10.1016/j.amjms.2020.07.011. Epub 2020 Jul 10. Am J Med Sci. 2020. PMID: 32723516 Review.
-
[Fabry disease: A review].Rev Med Interne. 2021 Feb;42(2):110-119. doi: 10.1016/j.revmed.2020.08.019. Epub 2020 Nov 7. Rev Med Interne. 2021. PMID: 33172708 Review. French.
Cited by
-
Correlation of enzyme activities and genotype with clinical manifestations in Chinese patients of different sexes with classical and late-onset Fabry disease.Front Med. 2025 Jun;19(3):523-537. doi: 10.1007/s11684-025-1131-9. Epub 2025 May 13. Front Med. 2025. PMID: 40358875
-
Establishing Treatment Effectiveness in Fabry Disease: Observation-Based Recommendations for Improvement.Int J Mol Sci. 2024 Sep 9;25(17):9752. doi: 10.3390/ijms25179752. Int J Mol Sci. 2024. PMID: 39273698 Free PMC article. Review.
-
A phase 4, open-label, multicenter study of the safety and efficacy of agalsidase beta in Chinese patients with Fabry disease.Orphanet J Rare Dis. 2025 Aug 4;20(1):401. doi: 10.1186/s13023-025-03950-7. Orphanet J Rare Dis. 2025. PMID: 40760696 Free PMC article. Clinical Trial.
-
Diagnosing Fabry nephropathy: the challenge of multiple kidney disease.BMC Nephrol. 2023 Nov 21;24(1):344. doi: 10.1186/s12882-023-03388-8. BMC Nephrol. 2023. PMID: 37990184 Free PMC article. Review.
References
-
- Fabry J. Ein Beitrag zur Kenntniss der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae) Arch Dermatol Syphilol. 1898;43(1):187–200. doi: 10.1007/BF01986897. - DOI
-
- Anderson W. A case of “angeio-keratoma. Br J Dermatol. 2010;10(4):113–7. doi: 10.1111/j.1365-2133.1898.tb16317.x. - DOI
-
- Schiffmann R, Hughes DA, Linthorst GE et al. Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney Int. 2017;91(2):284–293. 10.1016/j.kint.2016.10.004 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical